AMYRIS TO PRESENT AT THE 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Rhea-AI Summary

Amyris, a leading synthetic biotechnology company, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 11:15 am ET. This conference serves as a key platform for industry leaders, attracting significant attention from investors and analysts. A live webcast and replay of the presentation will be accessible on Amyris' Investor Relations page. The company focuses on sustainable ingredients in Clean Health & Beauty and Flavors & Fragrances, reaching over 300 million consumers.

EMERYVILLE, Calif., Jan. 5, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will present at the 40^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 11:15 am ET.

A live webcast of the presentation and a replay will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.

About Amyris

Amyris is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ operating platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products.

Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301454301.html

SOURCE Amyris, Inc.

FAQ

When will Amyris present at the J.P. Morgan Healthcare Conference?

Amyris will present on January 12, 2022, at 11:15 am ET.

Where can I watch the Amyris presentation from the conference?

The presentation will be available via a live webcast on the Investor Relations section of Amyris' website.

What is Amyris known for?

Amyris specializes in synthetic biotechnology, focusing on sustainable ingredients for Clean Health & Beauty and Flavors & Fragrances markets.

How many consumers do Amyris products reach?

Amyris products reach over 300 million consumers worldwide.

What operating platform does Amyris use?

Amyris utilizes its proprietary Lab-to-Market™ operating platform to innovate and produce sustainable ingredients.